Who are Evening primrose oil(EPO)'s main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/evening-primrose-oil-epo.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Evening primrose oil(EPO) — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evening primrose oil(EPO) (Evening primrose oil(EPO)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Botanical/Nutraceutical supplement; omega-6 polyunsaturated fatty acid source. Area: Rheumatology; Immunology; Inflammatory disorders.

phase 3 Botanical/Nutraceutical supplement; omega-6 polyunsaturated fatty acid source Rheumatology; Immunology; Inflammatory disorders Small molecule Live · refreshed every 30 min

Target snapshot

Evening primrose oil(EPO) (Evening primrose oil(EPO)) — Ain Shams University. Evening primrose oil provides gamma-linolenic acid (GLA), a polyunsaturated fatty acid that is converted to anti-inflammatory metabolites, primarily dihomo-gamma-linolenic acid (DGLA) and arachidonic acid derivatives.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Evening primrose oil(EPO) TARGET	Evening primrose oil(EPO)	Ain Shams University	phase 3	Botanical/Nutraceutical supplement; omega-6 polyunsaturated fatty acid source

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Botanical/Nutraceutical supplement; omega-6 polyunsaturated fatty acid source class)

Ain Shams University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Evening primrose oil(EPO) — Competitive Intelligence Brief. https://druglandscape.com/ci/evening-primrose-oil-epo. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab